Replies to post #94550 on $heff's $tation of $tocks & $olid DD

[buckiii2]

I am not in it. Sheff has this as a lotto play. Buy at your own risk level.

[buckiii2]

A+C, >> time frame for next results <<


Here's a repost (see below), for now this is all we know -


>>> Company guidance for the release of the CX-1739 Phase 2 RD results is '3rd Quarter', so sometime in the July/Aug/Sept period. Final data collection for the trial was the end of May. I'm figuring sometime around the R/S (shareholder vote is Aug 16) but that's just a guess. When the stock spiked recently I thought that perhaps the results had leaked (?), but also just a guess. Dr. Manuso may have given a timeline update at the recent Cantor Fitzgerald presentation, but it wasn't webcast and we haven't heard anything on I-Hub from anyone who attended.

The Dronabinol Phase 2 results I'm figuring will come later in the Fall. The final data collection for this trial occurred in May. This trial is being paid for and run by the NIH, so RSPI doesn't have as much control over when the data is released. <<<

Hopefully the rs goes like, LJPC.

[BioHunter]

$RSPI Senderos, Buckiii2...reverse split question

It can work both ways, really depends on doing R/S into weakness or strength. So if $RSPI splits pre-data -weakness, after CX-1739 data next few weeks- neutral, after second asset Dronabinol- strength.

This IS a LOTTO pick, we don't usually play lotto's on this board 1 or 2 a year always adds some fun:)

-BioHunter